{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T20:44:50Z","timestamp":1772657090768,"version":"3.50.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,3,28]],"date-time":"2017-03-28T00:00:00Z","timestamp":1490659200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81201762"],"award-info":[{"award-number":["81201762"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National High Technology Research and Development Program","award":["2014AA021605"],"award-info":[{"award-number":["2014AA021605"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Biochem Biotechnol"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1007\/s12010-017-2456-x","type":"journal-article","created":{"date-parts":[[2017,3,28]],"date-time":"2017-03-28T01:37:51Z","timestamp":1490665071000},"page":"444-459","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["The Inhibitory Effect of Mesenchymal Stem Cells with rAd-NK4 on Liver Cancer"],"prefix":"10.1007","volume":"183","author":[{"given":"Chao","family":"Cai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingling","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingsi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diandian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Honggang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinsheng","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weijun","family":"Guan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuehui","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,3,28]]},"reference":[{"key":"2456_CR1","first-page":"393","volume":"3","author":"AJ Friedenstein","year":"1970","unstructured":"Friedenstein, A. J., Chailakhjan, R. K., & Lalykina, K. S. (1970). The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell and Tissue Kinetics, 3, 393\u2013403.","journal-title":"Cell and Tissue Kinetics"},{"key":"2456_CR2","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000141739","volume":"45","author":"AJ Friedenstein","year":"1961","unstructured":"Friedenstein, A. J. (1961). Osteogenetic activity of transplanted transitional epithelium. Acta Anatomica (Basel), 45, 31\u201359.","journal-title":"Acta Anatomica (Basel)"},{"key":"2456_CR3","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1634\/stemcells.2005-0342","volume":"24","author":"S Kern","year":"2006","unstructured":"Kern, S., Eichler, H., Stoeve, J., et al. (2006). Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells, 24, 1294\u20131301.","journal-title":"Stem Cells"},{"key":"2456_CR4","doi-asserted-by":"publisher","first-page":"194","DOI":"10.3389\/fnins.2013.00194","volume":"7","author":"M Castillo-Melendez","year":"2013","unstructured":"Castillo-Melendez, M., Yawno, T., Jenkin, G., et al. (2013). Stem cell therapy to protect and repair the developing brain: a review of mechanisms of action of cord blood and amnion epithelial derived cells. Frontiers in Neuroscience, 7, 194. doi:\n10.3389\/fnins.2013.00194\n\n.","journal-title":"Frontiers in Neuroscience"},{"key":"2456_CR5","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1634\/stemcells.21-1-105","volume":"21","author":"YA Romanov","year":"2003","unstructured":"Romanov, Y. A., Svintsitskaya, V. A., & Smirnov, V. N. (2003). Searching for alternative sources of postnatal human mesenchymal stem cells: candidate MSC-like cells from umbilical cord. Stem Cells, 21, 105\u2013110.","journal-title":"Stem Cells"},{"key":"2456_CR6","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1634\/stemcells.2007-0439","volume":"26","author":"DL Troyer","year":"2008","unstructured":"Troyer, D. L., & Weiss, M. L. (2008). Wharton\u2019s jelly-derived cells are a primitive stromal cell population. Stem Cells, 26, 591\u2013599.","journal-title":"Stem Cells"},{"key":"2456_CR7","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.placenta.2008.09.009","volume":"30","author":"S Ilancheran","year":"2009","unstructured":"Ilancheran, S., Moodley, Y., & Manuelpillai, U. (2009). Human fetal membranes: a source of stem cells for tissue regeneration and repair? Placenta, 30, 2\u201310.","journal-title":"Placenta"},{"key":"2456_CR8","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s12010-008-8505-8","volume":"160","author":"F Xu","year":"2010","unstructured":"Xu, F., Yang, C. C., Gomillion, C., et al. (2010). Effect of ceramide on mesenchymal stem cell differentiation toward adipocytes. Applied Biochemistry and Biotechnology, 160, 197\u2013212.","journal-title":"Applied Biochemistry and Biotechnology"},{"key":"2456_CR9","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/cei.12111","volume":"173","author":"P Cipriani","year":"2013","unstructured":"Cipriani, P., Di Benedetto, P., Liakouli, V., et al. (2013). Mesenchymal stem cells (MSCs) from scleroderma patients (SSc) preserve their immunomodulatory properties although senescent and normally induce T regulatory cells (Tregs) with a functional phenotype: implications for cellular-based therapy. Clinical and Experimental Immunology, 173, 195\u2013206.","journal-title":"Clinical and Experimental Immunology"},{"key":"2456_CR10","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1080\/02656730802253117","volume":"24","author":"H Park","year":"2008","unstructured":"Park, H., Cho, J. A., Kim, S. K., et al. (2008). Hyperthermia on mesenchymal stem cells (MSCs) can sensitize tumor cells to undergo cell death. International Journal of Hyperthermia, 24, 638\u2013648.","journal-title":"International Journal of Hyperthermia"},{"key":"2456_CR11","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1007\/s13277-013-1165-5","volume":"35","author":"L Hou","year":"2014","unstructured":"Hou, L., Wang, X., Zhou, Y., et al. (2014). Inhibitory effect and mechanism of mesenchymal stem cells on liver cancer cells. Tumour Biology, 35, 1239\u20131250.","journal-title":"Tumour Biology"},{"key":"2456_CR12","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.4161\/cbt.21347","volume":"13","author":"B Zhang","year":"2012","unstructured":"Zhang, B., Shan, H., Li, D., et al. (2012). The inhibitory effect of MSCs expressing TRAIL as a cellular delivery vehicle in combination with cisplatin on hepatocellular carcinoma. Cancer Biology & Therapy, 13, 1175\u20131184.","journal-title":"Cancer Biology & Therapy"},{"key":"2456_CR13","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00395-009-0065-8","volume":"105","author":"K Takemiya","year":"2010","unstructured":"Takemiya, K., Kai, H., Yasukawa, H., et al. (2010). Mesenchymal stem cell-based prostacyclin synthase gene therapy for pulmonary hypertension rats. Basic Research in Cardiology, 105, 409\u2013417.","journal-title":"Basic Research in Cardiology"},{"key":"2456_CR14","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/gt.2013.88","volume":"21","author":"Q Deng","year":"2014","unstructured":"Deng, Q., Zhang, Z., Feng, X., et al. (2014). TRAIL-secreting mesenchymal stem cells promote apoptosis in heat-shock-treated liver cancer cells and inhibit tumor growth in nude mice. Gene Therapy, 21, 317\u2013327.","journal-title":"Gene Therapy"},{"key":"2456_CR15","doi-asserted-by":"crossref","first-page":"32","DOI":"10.2174\/157488808783489462","volume":"3","author":"V Fritz","year":"2008","unstructured":"Fritz, V., & Jorgensen, C. (2008). Mesenchymal stem cells: an emerging tool for cancer targeting and therapy. Current Stem Cell Research & Therapy, 3, 32\u201342.","journal-title":"Current Stem Cell Research & Therapy"},{"key":"2456_CR16","doi-asserted-by":"crossref","first-page":"4134","DOI":"10.1158\/0008-5472.CAN-08-4698","volume":"69","author":"MR Loebinger","year":"2009","unstructured":"Loebinger, M. R., Eddaoudi, A., Davies, D., et al. (2009). Mesenchymal stem cell delivery of TRAIL can eliminate metastatic cancer. Cancer Research, 69, 4134\u20134142.","journal-title":"Cancer Research"},{"key":"2456_CR17","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1007\/s00381-005-1216-3","volume":"21","author":"SG Kang","year":"2005","unstructured":"Kang, S. G., Jeun, S. S., Lim, J. Y., et al. (2005). Cytotoxicity of rat marrow stromal cells against malignant glioma cells. Child\u2019s Nervous System, 21, 528\u2013538.","journal-title":"Child\u2019s Nervous System"},{"key":"2456_CR18","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1038\/gt.2008.101","volume":"15","author":"C Ren","year":"2008","unstructured":"Ren, C., Kumar, S., Chanda, D., et al. (2008). Cancer gene therapy using mesenchymal stem cells expressing interferon-beta in a mouse prostate cancer lung metastasis model. Gene Therapy, 15, 1446\u20131453.","journal-title":"Gene Therapy"},{"key":"2456_CR19","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1177\/147323001204000132","volume":"40","author":"GX Wang","year":"2012","unstructured":"Wang, G. X., Zhan, Y. A., Hu, H. L., et al. (2012). Mesenchymal stem cells modified to express interferon-beta inhibit the growth of prostate cancer in a mouse model. The Journal of International Medical Research, 40, 317\u2013327.","journal-title":"The Journal of International Medical Research"},{"key":"2456_CR20","doi-asserted-by":"crossref","first-page":"781","DOI":"10.3892\/or.2013.2898","volume":"31","author":"J Jiang","year":"2014","unstructured":"Jiang, J., Wei, D., Sun, L., et al. (2014). A preliminary study on the construction of double suicide gene delivery vectors by mesenchymal stem cells and the in vitro inhibitory effects on SKOV3 cells. Oncology Reports, 31, 781\u2013787.","journal-title":"Oncology Reports"},{"key":"2456_CR21","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/sj.bjc.6603884","volume":"97","author":"PC Ma","year":"2007","unstructured":"Ma, P. C., Tretiakova, M. S., Nallasura, V., et al. (2007). Downstream signalling and specific inhibition of c-MET\/HGF pathway in small cell lung cancer: implications for tumour invasion. British Journal of Cancer, 97, 368\u2013377.","journal-title":"British Journal of Cancer"},{"key":"2456_CR22","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.bbrc.2006.07.040","volume":"347","author":"A Maeda","year":"2006","unstructured":"Maeda, A., Nakashiro, K., Hara, S., et al. (2006). Inactivation of AR activates HGF\/c-Met system in human prostatic carcinoma cells. Biochemical and Biophysical Research Communications, 347, 1158\u20131165.","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"2456_CR23","doi-asserted-by":"crossref","first-page":"535","DOI":"10.3892\/ijo.2012.1728","volume":"42","author":"A Matsumura","year":"2013","unstructured":"Matsumura, A., Kubota, T., Taiyoh, H., et al. (2013). HGF regulates VEGF expression via the c-Met receptor downstream pathways, PI3K\/Akt, MAPK and STAT3, in CT26 murine cells. International Journal of Oncology, 42, 535\u2013542.","journal-title":"International Journal of Oncology"},{"key":"2456_CR24","doi-asserted-by":"crossref","first-page":"10090","DOI":"10.1158\/0008-5472.CAN-10-0489","volume":"70","author":"F Shojaei","year":"2010","unstructured":"Shojaei, F., Lee, J. H., Simmons, B. H., et al. (2010). HGF\/c-Met acts as an alternative angiogenic pathway in sunitinib-resistant tumors. Cancer Research, 70, 10090\u201310100.","journal-title":"Cancer Research"},{"key":"2456_CR25","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/(SICI)1097-4652(199909)180:3<365::AID-JCP7>3.0.CO;2-B","volume":"180","author":"A Luca de","year":"1999","unstructured":"de Luca, A., Arena, N., Sena, L. M., et al. (1999). Met overexpression confers HGF-dependent invasive phenotype to human thyroid carcinoma cells in vitro. Journal of Cellular Physiology, 180, 365\u2013371.","journal-title":"Journal of Cellular Physiology"},{"key":"2456_CR26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-5793(97)01475-0","volume":"420","author":"K Date","year":"1997","unstructured":"Date, K., Matsumoto, K., Shimura, H., et al. (1997). HGF\/NK4 is a specific antagonist for pleiotrophic actions of hepatocyte growth factor. FEBS Letters, 420, 1\u20136.","journal-title":"FEBS Letters"},{"key":"2456_CR27","first-page":"6737","volume":"60","author":"K Kuba","year":"2000","unstructured":"Kuba, K., Matsumoto, K., Date, K., et al. (2000). HGF\/NK4, a four-kringle antagonist of hepatocyte growth factor, is an angiogenesis inhibitor that suppresses tumor growth and metastasis in mice. Cancer Research, 60, 6737\u20136743.","journal-title":"Cancer Research"},{"key":"2456_CR28","doi-asserted-by":"crossref","first-page":"22491","DOI":"10.1074\/jbc.M109.025148","volume":"284","author":"K Sakai","year":"2009","unstructured":"Sakai, K., Nakamura, T., Matsumoto, K., et al. (2009). Angioinhibitory action of NK4 involves impaired extracellular assembly of fibronectin mediated by perlecan-NK4 association. The Journal of Biological Chemistry, 284, 22491\u201322499.","journal-title":"The Journal of Biological Chemistry"},{"key":"2456_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0042717","volume":"7","author":"E Ozen","year":"2012","unstructured":"Ozen, E., Gozukizi, A., Erdal, E., et al. (2012). Heparin inhibits hepatocyte growth factor induced motility and invasion of hepatocellular carcinoma cells through early growth response protein 1. PloS One, 7, e42717. doi:\n10.1371\/journal.pone.0042717\n\n.","journal-title":"PloS One"},{"key":"2456_CR30","doi-asserted-by":"publisher","first-page":"806891","DOI":"10.1155\/2011\/806891","volume":"2011","author":"S Seo","year":"2011","unstructured":"Seo, S., & Na, K. (2011). Mesenchymal stem cell-based tissue engineering for chondrogenesis. Journal of Biomedicine & Biotechnology, 2011, 806891. doi:\n10.1155\/2011\/806891\n\n.","journal-title":"Journal of Biomedicine & Biotechnology"},{"key":"2456_CR31","doi-asserted-by":"crossref","first-page":"6207","DOI":"10.1016\/j.biomaterials.2010.04.054","volume":"31","author":"AK Sharma","year":"2010","unstructured":"Sharma, A. K., Hota, P. V., Matoka, D. J., et al. (2010). Urinary bladder smooth muscle regeneration utilizing bone marrow derived mesenchymal stem cell seeded elastomeric poly(1,8-octanediol-co-citrate) based thin films. Biomaterials, 31, 6207\u20136217.","journal-title":"Biomaterials"},{"key":"2456_CR32","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s12010-014-1128-3","volume":"174","author":"T Lu","year":"2014","unstructured":"Lu, T., Xiong, H., Wang, K., et al. (2014). Isolation and characterization of adipose-derived mesenchymal stem cells (ADSCs) from cattle. Applied Biochemistry and Biotechnology, 174, 719\u2013728.","journal-title":"Applied Biochemistry and Biotechnology"},{"key":"2456_CR33","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1073\/pnas.0308065101","volume":"101","author":"C Saucier","year":"2004","unstructured":"Saucier, C., Khoury, H., La, K. M., et al. (2004). The Shc adaptor protein is critical for VEGF induction by Met\/HGF and ErbB2 receptors and for early onset of tumor angiogenesis. Proceedings of the National Academy of Sciences of the United States of America, 101, 2345\u20132350.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"2456_CR34","first-page":"301","volume":"65","author":"EM Rosen","year":"1993","unstructured":"Rosen, E. M., Zitnik, R. J., Elias, J. A., et al. (1993). The interaction of HGF-SF with other cytokines in tumor invasion and angiogenesis. EXS, 65, 301\u2013310.","journal-title":"EXS"},{"key":"2456_CR35","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.ajpath.2012.05.023","volume":"181","author":"S Takeuchi","year":"2012","unstructured":"Takeuchi, S., Wang, W., Li, Q., et al. (2012). Dual inhibition of Met kinase and angiogenesis to overcome HGF-induced EGFR-TKI resistance in EGFR mutant lung cancer. The American Journal of Pathology, 181, 1034\u20131043.","journal-title":"The American Journal of Pathology"},{"key":"2456_CR36","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/ijc.11220","volume":"106","author":"G Davies","year":"2003","unstructured":"Davies, G., Mason, M. D., Martin, T. A., et al. (2003). The HGF\/SF antagonist NK4 reverses fibroblast- and HGF-induced prostate tumor growth and angiogenesis in vivo. International Journal of Cancer, 106, 348\u2013354.","journal-title":"International Journal of Cancer"},{"key":"2456_CR37","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/ijc.29391","volume":"137","author":"XB Deng","year":"2015","unstructured":"Deng, X. B., Xiao, L., Wu, Y., et al. (2015). Inhibition of mesothelioma cancer stem-like cells with adenovirus-mediated NK4 gene therapy. International Journal of Cancer, 137, 481\u2013490.","journal-title":"International Journal of Cancer"},{"key":"2456_CR38","doi-asserted-by":"crossref","first-page":"567","DOI":"10.3892\/or.2013.2509","volume":"30","author":"T Kubota","year":"2013","unstructured":"Kubota, T., Matsumura, A., Taiyoh, H., et al. (2013). Interruption of the HGF paracrine loop by NK4, an HGF antagonist, reduces VEGF expression of CT26 cells. Oncology Reports, 30, 567\u2013572.","journal-title":"Oncology Reports"},{"key":"2456_CR39","doi-asserted-by":"crossref","first-page":"5047","DOI":"10.1038\/onc.2013.458","volume":"33","author":"C Xu","year":"2014","unstructured":"Xu, C., Lin, L., Cao, G., et al. (2014). Interferon-alpha-secreting mesenchymal stem cells exert potent antitumor effect in vivo. Oncogene, 33, 5047\u20135052.","journal-title":"Oncogene"},{"key":"2456_CR40","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.scr.2013.09.010","volume":"12","author":"BR Yi","year":"2014","unstructured":"Yi, B. R., Hwang, K. A., Aboody, K. S., et al. (2014). Selective antitumor effect of neural stem cells expressing cytosine deaminase and interferon-beta against ductal breast cancer cells in cellular and xenograft models. Stem Cell Research, 12, 36\u201348.","journal-title":"Stem Cell Research"},{"key":"2456_CR41","doi-asserted-by":"crossref","first-page":"600","DOI":"10.2967\/jnumed.114.146662","volume":"56","author":"K Knoop","year":"2015","unstructured":"Knoop, K., Schwenk, N., Schmohl, K., et al. (2015). Mesenchymal stem cell-mediated, tumor stroma-targeted radioiodine therapy of metastatic colon cancer using the sodium iodide symporter as theranostic gene. Journal of Nuclear Medicine, 56, 600\u2013606.","journal-title":"Journal of Nuclear Medicine"},{"key":"2456_CR42","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/cr.2008.40","volume":"18","author":"L Qiao","year":"2008","unstructured":"Qiao, L., Xu, Z., Zhao, T., et al. (2008). Suppression of tumorigenesis by human mesenchymal stem cells in a hepatoma model. Cell Research, 18, 500\u2013507.","journal-title":"Cell Research"},{"key":"2456_CR43","doi-asserted-by":"publisher","first-page":"8230","DOI":"10.1038\/srep08230","volume":"5","author":"X Cao","year":"2015","unstructured":"Cao, X., Li, Y., Luo, R. Z., et al. (2015). Expression of Cystatin SN significantly correlates with recurrence, metastasis, and survival duration in surgically resected non-small cell lung cancer patients. Scientific Reports, 5, 8230. doi:\n10.1038\/srep08230\n\n.","journal-title":"Scientific Reports"},{"key":"2456_CR44","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/mc.22290","volume":"55","author":"C Tan","year":"2015","unstructured":"Tan, C., Qiao, F., Wei, P., et al. (2015). DIXDC1 activates the Wnt signaling pathway and promotes gastric cancer cell invasion and metastasis. Molecular Carcinogenesis, 55, 397\u2013408.","journal-title":"Molecular Carcinogenesis"},{"key":"2456_CR45","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.gdata.2014.06.007","volume":"2","author":"DM Marzese","year":"2014","unstructured":"Marzese, D. M., Huynh, J. L., Kawas, N. P., et al. (2014). Multi-platform genome-wide analysis of melanoma progression to brain metastasis. Genom Data, 2, 150\u2013152.","journal-title":"Genom Data"},{"key":"2456_CR46","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s12010-015-1505-6","volume":"176","author":"L Zhang","year":"2015","unstructured":"Zhang, L., Sun, J., Wang, B., et al. (2015). MicroRNA-10b triggers the epithelial-mesenchymal transition (EMT) of laryngeal carcinoma Hep-2 cells by directly targeting the E-cadherin. Applied Biochemistry and Biotechnology, 176, 33\u201344.","journal-title":"Applied Biochemistry and Biotechnology"},{"key":"2456_CR47","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ejphar.2015.03.088","volume":"778","author":"G Marone","year":"2015","unstructured":"Marone, G., Varicchi, G., Loffredo, S., et al. (2015). Mast cells and basophils in inflammatory and tumor angiogenesis and lymphangiogenesis. European Journal of Pharmacology, 778, 146\u2013151.","journal-title":"European Journal of Pharmacology"},{"key":"2456_CR48","doi-asserted-by":"crossref","first-page":"3237","DOI":"10.1007\/s13277-014-2952-3","volume":"36","author":"H Akrami","year":"2015","unstructured":"Akrami, H., Aminzadeh, S., & Fallahi, H. (2015). Inhibitory effect of ibuprofen on tumor survival and angiogenesis in gastric cancer cell. Tumour Biology, 36, 3237\u20133243.","journal-title":"Tumour Biology"},{"key":"2456_CR49","doi-asserted-by":"crossref","first-page":"4758","DOI":"10.1038\/onc.2014.411","volume":"34","author":"L Zeng","year":"2014","unstructured":"Zeng, L., Morinibu, A., Kobayashi, M., et al. (2014). Aberrant IDH3alpha expression promotes malignant tumor growth by inducing HIF-1-mediated metabolic reprogramming and angiogenesis. Oncogene, 34, 4758\u20134766.","journal-title":"Oncogene"},{"key":"2456_CR50","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/s12010-013-0344-6","volume":"171","author":"RA Chougule","year":"2013","unstructured":"Chougule, R. A., P, S., Salimath, B. P., et al. (2013). Buffalo colostrum \u03b2-lactoglobulin inhibits VEGF-induced angiogenesis by interacting with G protein-coupled receptor kinase. Applied Biochemistry and Biotechnology, 171, 366\u2013381.","journal-title":"Applied Biochemistry and Biotechnology"},{"key":"2456_CR51","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1007\/s12010-015-1695-y","volume":"176","author":"W Ebrahimizadeh","year":"2015","unstructured":"Ebrahimizadeh, W., Mousavi Gargari, S. L., Javidan, Z., et al. (2015). Production of novel VHH nanobody inhibiting angiogenesis by targeting binding site of VEGF. Applied Biochemistry and Biotechnology, 176, 1985\u20131995.","journal-title":"Applied Biochemistry and Biotechnology"}],"updated-by":[{"DOI":"10.1007\/s12010-018-2748-9","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2018,4,11]],"date-time":"2018-04-11T00:00:00Z","timestamp":1523404800000}}],"container-title":["Applied Biochemistry and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12010-017-2456-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-017-2456-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-017-2456-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,9,5]],"date-time":"2017-09-05T04:33:55Z","timestamp":1504586035000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12010-017-2456-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,28]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["2456"],"URL":"https:\/\/doi.org\/10.1007\/s12010-017-2456-x","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s12010-018-2748-9","asserted-by":"object"}]},"ISSN":["0273-2289","1559-0291"],"issn-type":[{"value":"0273-2289","type":"print"},{"value":"1559-0291","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,28]]}}}